Solid tumors present immense complexity, characterized by significant intra-tumoral heterogeneity (ITH) arising from genetic, epigenetic, and transcriptional diversity. Understanding this heterogeneity, including the distinct cell states, their plasticity, and interactions within the tumor microenvironment (TME), is paramount for developing effective targeted therapies and overcoming treatment resistance.